Hjem » Gastroenterologi » Legemiddelmonitorering »
Shikari
- Each kit’s dynamic measurement range optimized for Cmax-Cmin (trough) values of the drugs. Also, researchers can also measure biological levels of the drugs in human, mouse, rat and monkey serum or plasma samples for pharmacokinetic studies.
- More than 150 publications has been made by using SHIKARI® ELISA kits.
- All SHIKARI® ELISA kits are validated in compliance with international standards and easy to publish results.
- Quantitative ELISA kits for anti-drug antibodies (immunogenicity) with confirmation reagent available for 18 different biological drugs. Matriks Biotek® is the first biotechnology company which produced ELISA kits for Remsima® (Infliximab Biosimilar CT-P13). Kits for Remsima® includes quantitative free drug detection kits, qualitative Anti-Remsima® detection kits and total antibody detection kits for Remsima®.
- Total antibody (DUO) kits have been developed to identify anti-drug antibodies that are bound by drugs in the serum and cannot be determined by free antibody detection kits. Matriks Biotek® developed total antibody detection kits for 3 different drugs: Infliximab (Remicade®, Remsima®) and Adalimumab (Humira®). These DUO kits also measure free anti-drug antibodies simultaneously allowing comparisons between total and free anti-drug antibodies giving semi-quantitative results. Kits are unique in the market. Total antibody detection kit development studies for different drugs are ongoing, please inquire.
- Quantitative ADA detection kits include confirmation reagent to eliminate false positives when reporting the results. Unique in the market.
- High recovery rates (%85-115)
- Low sample volumes (10-25 µl) even if you have very small samples such as mouse serum
- All liquid and highly stabilized ready to use reagents
- Delivery is at room temperature.
- The highest quality material used.
Microplates NUNC®, Perfect binding of proteins minimum %CV across the entire plate and perfect match with our proprietary blocking buffer almost no background with very long shelf life.
Plastic bottles Nalgene® very durable with perfect surface property.
Glass vials Schott® used for standard containers; vigorously tested. No protein binding clear glass w/ cap when compared to other brands
- All kits are in 96 well format and you can run as much as 90 samples from each kit.
- 1 year expiry date/Short delivery times
- Project development for custom ELISA kits to measure PK and immunogenicity for your specific biosimilar or original molecule.
- Kits are suitable for biosimilar work. Kits utilize recombinant human proteins ligand binding assay
- All Shikari® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
SHIKARI ELISA kits
Legemidler
| ABATACEPT | ECULIZUMAB | OMALIZUMAB |
| ADALIMUMAB | ETANERCEPT | PALIVIZUMAB |
| AFLIBERCEPT | EVOLOCUMAB | PEMBROLIZUMAB |
| ATEZOLIZUMAB | FILGRASTIM | PERTUZUMAB |
| AVELUMAB | GOLIMUMAB | RAMUCIRUMAB |
| BEVACIZUMAB | INFLIXIMAB | RANIBIZUMAB |
| CANAKINUMAB | INFLIXIMAB-BIOSIMILAR | RISANKIZUMAB |
| CERTOLIZUMAB | IPILIMUMAB | RITUXIMAB |
| CETUXIMAB | IXEKIZUMAB | SECUKINUMAB |
| DARATUMUMAB | NATALIZUMAB | TOCILIZUMAB |
| DENOSUMAB | NIVOLUMAB | TRASTUZUMAB |
| DURVALUMAB | OCRELIZUMAB | USTEKINUMAB |
| VEDOLIZUMAB | ||